<i>Candida auris</i>, what do paediatricians need to know?
Where this comes from
- Record sourced from PubMed, PMID 29545411.
- Also identified by DOI 10.1136/archdischild-2017-313960 and PMC identifier 6104675.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The newly recognised and emerging fungal species, <i>Candida auris</i>, has caused worldwide invasive infections and has been implicated in difficult to control hospital outbreaks. Challenges are encountered in the correct identification of this fungus as commonly used phenotypic and biochemical methods fail to differentiate <i>C. auris</i> from other <i>Candida</i> species. Its resistance profile, over 90% of isolates are fluconazole resistant and 35% are resistant to amphotericin, confronts clinicians with the restricted arsenal of antifungals and concerns about optimal treatment. The very first <i>C. auris</i> isolate was recovered from a paediatric patient in retrospect. Although infections with the more antifungal-resistant <i>Candida</i> species are less frequently observed in paediatric patients, this seems to be different for <i>C. auris</i> infections.
Medical subject headings
- Candida
- Candidiasis